Form 4 holding
Director, 10%+ Owner
BriaCell Therapeutics Corp.
- Security class
- Common Shares
- Shares / value
- 2,542,935
- Estimated value
- $5,632,601
- Report date
- 14 May 2024
- Price
- $2.22
- Ownership
- By L5 Capital Inc.
Marc Lustig
Insider Reports History
- Reporting-owner location
- West Vancouver, British Columbia, Canada
- Latest reporting-owner signature
-
/s/ Marc Lustig
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Marc Lustig
Form 4 holding
Director, 10%+ Owner
BriaCell Therapeutics Corp.
- Security class
- Common Stock Warrants
- Shares / value
- 902,935
- Estimated value
- Report date
- 14 May 2024
- Price
- Ownership
- By L5 Capital Inc.
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Marc Lustig
4
BCTX
BriaCell Therapeutics Corp.
- Report period
- 14 May 2024
- Transactions
- 2
- Transaction value
- +$2,000,001
- Accepted by SEC
- 20 May 2024, 16:00
- Role
- Director, 10%+ Owner
- Next action
- Open filing details
3
BCTX
BriaCell Therapeutics Corp.
- Report period
- 01 Aug 2022
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 02 Aug 2022, 16:07
- Role
- Director
- Next action
- Open filing details